Overview

A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant).

Status:
Completed
Trial end date:
2007-01-05
Target enrollment:
Participant gender:
Summary
This study will examine what the body does while taking GW679769 alone and together with rifampin in healthy adult subjects.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Casopitant
Rifampin